PBGC_RFP_16PBGC25R0052_Attachment_1_-_Pricing_Schedule.xlsx

XLSX spreadsheet 41 KB Posted May 13, 2025

Attached to: PBGC Active EME Investment Management Services
Solicitation number: 16PBGC25R0052
Issued by: Pension Benefit Guaranty Corporation

About this file

Written by GovTribe AI · May 13, 2025

This is a Pricing Schedule attachment for RFP No. 16PBGC25R0052 issued by the Pension Benefit Guaranty Corporation (PBGC) for Active Emerging Market Equity Investment Services. The pricing document outlines a comprehensive fee structure for two investment strategies: an Active Emerging Market Equity Investment and an optional Emerging Market ex-China Strategy. The procurement includes a 12-month base period followed by nine 12-month option periods, with an additional six-month option to extend services.

The pricing schedule is structured with consistent pricing tables across the base and option periods, with estimated asset levels of $375 million for the primary strategy and $50 million for the optional strategy. Offerors are required to submit detailed pricing proposals with fee breakpoints across multiple asset levels, using basis points as the pricing metric. The document instructs vendors to input data only in green bold italicized cells and provides multiple tabs for pricing different performance periods, with a total price summary calculated across all periods. No travel costs should be included in the price proposal, and the PBGC will use the specified asset levels for evaluation purposes to ensure comparable fee submissions.

View the file

Other files

File	Type	Posted
PBGC_RFP_16PBGC25R0052_0002_Attachment_2a_-_Phase_1_Mandatory_Requirements_Questionnaire_0002.pdf	PDF	Jul 11, 2025
PBGC_RFP_16PBGC25R0052_0002_Attachment_8_-_QandA_-_Final_0002.xlsx	XLSX spreadsheet	Jul 11, 2025
Sol_16PBGC25R0052_Amd_0003.pdf	PDF	Jul 11, 2025
Sol_16PBGC25R0052_Amd_0002.pdf	PDF	Jun 3, 2025
PBGC RFP 16PBGC25R0052 0002 Attachment 2a - Phase 1 Mandatory Requirements Questionnaire.pdf	PDF	Jun 3, 2025
PBGC RFP 16PBGC25R0052 0002 Attachment 8 - QandA - Final.xlsx	XLSX spreadsheet	Jun 3, 2025
Sol_16PBGC25R0052_Amd_0001_signed.pdf	PDF	Jun 3, 2025
PBGC_RFP_16PBGC25R0052_0001_Attachment_2b_-_Phase_1_Rolling_IR_Mandatory_Supporting_Documentation_0001.xlsx	XLSX spreadsheet	May 22, 2025
PBGC_RFP_16PBGC25R0052_0001_Attachment_5_-_Phase_2_Corporate_Experience_Questionnaire_0001.pdf	PDF	May 22, 2025
PBGC_RFP_16PBGC25R0052_0001_Active_EME_Management_Services_Solicitation_Cover_Letter_0001.pdf	PDF	May 22, 2025
Sol_16PBGC25R0052_Amd_0001.pdf	PDF	May 22, 2025
PBGC_RFP_16PBGC25R0052_0001_Attachment_2a_-_Phase_1_Mandatory_Requirements_Questionnaire_0001.pdf	PDF	May 22, 2025
PBGC_RFP_16PBGC25R0052_Attachment_3_-_Phase_2_Technical_Approach_Questionnaire.pdf	PDF	May 13, 2025
PBGC_RFP_16PBGC25R0052_Active_EME_Management_Services_Solicitation_Cover_Letter.pdf	PDF	May 13, 2025
PBGC_RFP_16PBGC25R0052_Attachment_2a_-_Phase_1_Mandatory_Requirements_Questionnaire.pdf	PDF	May 13, 2025
PBGC_RFP_16PBGC25R0052_Attachment_4_-_Phase_2_Firm_Resources_Questionnaire.pdf	PDF	May 13, 2025
PBGC_RFP_16PBGC25R0052_Attachment_5_-_Phase_2_Corporate_Experience_Questionnaire.pdf	PDF	May 13, 2025
Sol_16PBGC25R0052.pdf	PDF	May 13, 2025
PBGC_RFP_16PBGC25R0052_Attachment_7_-_Organizational_Conflict_of_Interest_Statement.docx	DOCX document	May 13, 2025
PBGC_RFP_16PBGC25R0052_Attachment_8_-_QandA_Template.xlsx	XLSX spreadsheet	May 13, 2025
PBGC_RFP_16PBGC25R0052_Attachment_2b_-_Phase_1_Rolling_IR_Mandatory_Supporting_Documentation.xlsx	XLSX spreadsheet	May 13, 2025
PBGC_RFP_16PBGC25R0052_Attachment_6_-_Phase_2_Excel_Tables_-_FIRM_NAME.xlsx	XLSX spreadsheet	May 13, 2025

Show all 22

On GovTribe

Work with this file

Download the original file
Contacts named in this file
Similar government files
Ask GovTribe AI about this file

Try for free Login

Text version

The file's text, extracted by GovTribe without its formatting.

Instructions

1. Only input data into cells with green bold italicized font.

2. Please note that the 52.217-8 - Option to Extend Services represents a period of performance for six months.

3. The total price summary is tabulated from all of the other periods of performance tabs.

Total Price Summary

Active Emerging Market Equity Investment Services
Total Price Summary Table
Base Period	$0.00
Option Period One	$0.00
Option Period Two	$0.00
Option Period Three	$0.00
Option Period Four	$0.00
Option Period Five	$0.00
Option Period Six	$0.00
Option Period Seven	$0.00
Option Period Eight	$0.00
Option Period Nine	$0.00
Overall Total Price	$0.00
52.217-8 - Option to Extend Services
Overall Total Price (including the 52.217-8)	$0.00

Price - Active EME

		Active Emerging Markets Equities Investment Management Services
		RFP No. 16PBGC25R0052
		Attachment 1 - Pricing Schedule
	Base Period
		CLIN 0001 - Activer Emerging Market Equity Investment (Based on an estimated $375M)
		Product Name	Price proposed
(in basis points)		AUM	Total Fees
				on the first
				on the next	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				On the balance	$ - 0
		CLIN 0001 Total Price
	Update the table above as necessary to show the necessary number of tiers.

		CLIN 0002 [OPTIONAL] - Emerging Market ex-China Strategy (Based on an estimated $50M)
		Product Name	Price proposed
(in basis points)		AUM	Total Fees
				on the first	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				On the balance	$ - 0
		CLIN 0002 Total Price
	Update the table above as necessary to show the necessary number of tiers.

BASE PERIOD TOTAL PRICE

	Option Period 1
		CLIN 1001 - Activer Emerging Market Equity Investment (Based on an estimated $375M)
		Product Name	Price proposed
(in basis points)		AUM	Total Fees
				on the first	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				On the balance	$ - 0
		CLIN 1001 Total Price
	Update the table above as necessary to show the necessary number of tiers.

		CLIN 1002 [OPTIONAL] - Emerging Market ex-China Strategy (Based on an estimated $50M)
		Product Name	Price proposed
(in basis points)		AUM	Total Fees
				on the first	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				On the balance	$ - 0
		CLIN 1002 Total Price
	Update the table above as necessary to show the necessary number of tiers.

OPTION PERIOD 1 TOTAL PRICE

	Option Period 2
		CLIN 2001 - Activer Emerging Market Equity Investment (Based on an estimated $375M)
		Product Name	Price proposed
(in basis points)		AUM	Total Fees
				on the first	$ - 0	$ - 0
				on the next	$ - 0	$ - 0
				on the next	$ - 0	$ - 0
				on the next	$ - 0	$ - 0
				On the balance	$ - 0	$ - 0
		CLIN 2001 Total Price				$ - 0
	Update the table above as necessary to show the necessary number of tiers.

		CLIN 2002 [OPTIONAL] - Emerging Market ex-China Strategy (Based on an estimated $50M)
		Product Name	Price proposed
(in basis points)		AUM	Total Fees
				on the first	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				On the balance	$ - 0
		CLIN 2002 Total Price
	Update the table above as necessary to show the necessary number of tiers.

OPTION PERIOD 2 TOTAL PRICE

	Option Period 3
		CLIN 3001 - Activer Emerging Market Equity Investment (Based on an estimated $375M)
		Product Name	Price proposed
(in basis points)		AUM	Total Fees
				on the first	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				On the balance	$ - 0
		CLIN 3001 Total Price
	Update the table above as necessary to show the necessary number of tiers.

		CLIN 3002 [OPTIONAL] - Emerging Market ex-China Strategy (Based on an estimated $50M)
		Product Name	Price proposed
(in basis points)		AUM	Total Fees
				on the first	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				On the balance	$ - 0
		CLIN 3002 Total Price
	Update the table above as necessary to show the necessary number of tiers.

OPTION PERIOD 3 TOTAL PRICE

	Option Period 4
		CLIN 4001 - Activer Emerging Market Equity Investment (Based on an estimated $375M)
		Product Name	Price proposed
(in basis points)		AUM	Total Fees
				on the first	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				On the balance	$ - 0
		CLIN 4001 Total Price
	Update the table above as necessary to show the necessary number of tiers.

		CLIN 4002 [OPTIONAL] - Emerging Market ex-China Strategy (Based on an estimated $50M)
		Product Name	Price proposed
(in basis points)		AUM	Total Fees
				on the first	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				On the balance	$ - 0
		CLIN 4002 Total Price
	Update the table above as necessary to show the necessary number of tiers.

OPTION PERIOD 4 TOTAL PRICE

	Option Period 5
		CLIN 5001 - Activer Emerging Market Equity Investment (Based on an estimated $375M)
		Product Name	Price proposed
(in basis points)		AUM	Total Fees
				on the first	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				On the balance	$ - 0
		CLIN 5001 Total Price
	Update the table above as necessary to show the necessary number of tiers.

		CLIN 5002 [OPTIONAL] - Emerging Market ex-China Strategy (Based on an estimated $50M)
		Product Name	Price proposed
(in basis points)		AUM	Total Fees
				on the first	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				On the balance	$ - 0
		CLIN 5002 Total Price
	Update the table above as necessary to show the necessary number of tiers.

OPTION PERIOD 5 TOTAL PRICE

	Option Period 6
		CLIN 6001 - Activer Emerging Market Equity Investment (Based on an estimated $375M)
		Product Name	Price proposed
(in basis points)		AUM	Total Fees
				on the first	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				On the balance	$ - 0
		CLIN 6001 Total Price
	Update the table above as necessary to show the necessary number of tiers.

		CLIN 6002 [OPTIONAL] - Emerging Market ex-China Strategy (Based on an estimated $50M)
		Product Name	Price proposed
(in basis points)		AUM	Total Fees
				on the first	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				On the balance	$ - 0
		CLIN 6002 Total Price
	Update the table above as necessary to show the necessary number of tiers.

OPTION PERIOD 6 TOTAL PRICE

	Option Period 7
		CLIN 7001 - Activer Emerging Market Equity Investment (Based on an estimated $375M)
		Product Name	Price proposed
(in basis points)		AUM	Total Fees
				on the first	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				On the balance	$ - 0
		CLIN 7001 Total Price
	Update the table above as necessary to show the necessary number of tiers.

		CLIN 7002 [OPTIONAL] - Emerging Market ex-China Strategy (Based on an estimated $50M)
		Product Name	Price proposed
(in basis points)		AUM	Total Fees
				on the first	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				On the balance	$ - 0
		CLIN 7002 Total Price
	Update the table above as necessary to show the necessary number of tiers.

OPTION PERIOD 7 TOTAL PRICE

	Option Period 8
		CLIN 8001 - Activer Emerging Market Equity Investment (Based on an estimated $375M)
		Product Name	Price proposed
(in basis points)		AUM	Total Fees
				on the first	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				On the balance	$ - 0
		CLIN 8001 Total Price
	Update the table above as necessary to show the necessary number of tiers.

		CLIN 8002 [OPTIONAL] - Emerging Market ex-China Strategy (Based on an estimated $50M)
		Product Name	Price proposed
(in basis points)		AUM	Total Fees
				on the first	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				On the balance	$ - 0
		CLIN 8002 Total Price
	Update the table above as necessary to show the necessary number of tiers.

OPTION PERIOD 8 TOTAL PRICE

	Option Period 9
		CLIN 9001 - Activer Emerging Market Equity Investment (Based on an estimated $375M)
		Product Name	Price proposed
(in basis points)		AUM	Total Fees
				on the first	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				On the balance	$ - 0
		CLIN 9001 Total Price
	Update the table above as necessary to show the necessary number of tiers.

		CLIN 9002 [OPTIONAL] - Emerging Market ex-China Strategy (Based on an estimated $50M)
		Product Name	Price proposed
(in basis points)		AUM	Total Fees
				on the first	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				On the balance	$ - 0
		CLIN 9002 Total Price
	Update the table above as necessary to show the necessary number of tiers.

OPTION PERIOD 9 TOTAL PRICE

	FAR 52.217-8 Option to Extend Services (6 months)
		CLIN X001 - Activer Emerging Market Equity Investment (Based on an estimated $375M)
		Product Name	Price proposed
(in basis points)		AUM	Total Fees
				on the first	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				On the balance	$ - 0
		CLIN X001 Total Price
	Update the table above as necessary to show the necessary number of tiers.

		CLIN X002 [OPTIONAL] - Emerging Market ex-China Strategy (Based on an estimated $50M)
		Product Name	Price proposed
(in basis points)		AUM	Total Fees
				on the first	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				on the next	$ - 0
				On the balance	$ - 0
		CLIN X002 Total Price
	Update the table above as necessary to show the necessary number of tiers.

	FAR 52.217-8 Option to Extend Services (6 months) TOTAL PRICE
No travel costs should be included as part of the price proposal submission
NOTE: As identified in the Pricing Schedule above, the period of performance for this procurement is for 1 twelve-months base year and 9 twelve-months option years. Therefore, Offerors are required to submit pricing proposals for a base year and nine option years. The PBGC will use a $375 million asset level for Active Emerging Market Equity Investment and $50 million for optional Emerging Market ex-China Strategy for evaluation purposes only to provide comparable fees. However, Offerors should provide all breakpoints, both below and above the referenced asset levels.

image1.jpeg

File details come from the government source that posted it. Updated May 13, 2025.